Pharma News
We must stay vigilant on false patent extensions and the non-clinical use of weight-loss drugs
The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and Wegovy. We need cheap generics in as many treatment categories as possible. But we must also curb the misuse of weight-loss drugs to slim down without medical advice.
2 min read07:30 AM ISTDelhi HC division bench refuses stay on Dr Reddy’s semaglutide exports
The Delhi High Court ruled against Novo Nordisk's request to block Dr Reddy's production of semaglutide for export. The case will be reviewed in January, as Indian drugmakers prepare for a competitive market once the patent expires in 2026.
2 min read12 Dec 2025Novo Nordisk moves Delhi HC division bench to block Dr Reddy’s semaglutide exports
Novo Nordisk has approached the Delhi High Court to prevent Dr Reddy’s Laboratories from manufacturing and exporting semaglutide until March 2026.
2 min read11 Dec 2025As Big Pharma faces a 'patent cliff', China’s biotech boom is emerging as the industry’s most critical lifeline
As Big Pharma braces for a massive revenue crash when patents on blockbuster drugs expire, an unexpected player is stepping into the gap. China’s biotech sector is central could ally with Western drugmakers—unless geopolitics gets in the way.
3 min read11 Dec 2025French drugmaker Servier firms up India focus with manufacturing tie-ups, trial plans
The company recently received market authorization from the Indian drug regulator for its drug Vorasidenib, a first-in-class, oral therapy for adults or children over 12 with grade-2 gliomas or types of brain cancer, with specific genetic mutations.
2 min read10 Dec 2025WHO audit, India hopes, will restore shine to its ‘pharmacy of the world’ image
In response to drug safety issues, India plans to seek a WHO assessment of its regulatory system. Core regulatory functions such as inspections, approvals, and enforcement will be assessed and benchmarked in the initiative. This move follows incidents of contaminated drugs causing child deaths.
6 min read10 Dec 2025Delhi HC bars Sun Pharma from selling semaglutide in India until Novo's patent expires, but allows exports
The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this month.
2 min read10 Dec 2025Novo Nordisk moves Delhi HC to block Sun Pharma as weight loss drug patent expiry looms
Earlier, the court had declined Novo’s plea for an interim injunction against Dr Reddy’s Labs and permitted the company to manufacture and export semaglutide to non-patent countries until March 2026
2 min read9 Dec 2025Creador acquires 7% stake in pharma company La Renon
Creador’s purchase of shares from Peak XV comes about a decade after the venture capital firm first invested in the company.
2 min read8 Dec 2025Mint Explainer: Does India need special courts for complex drug patent wars?
Timelines for patent disputes in India can stretch years, often a setback for companies working with time-sensitive patent deadlines.
3 min read6 Dec 2025Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.